Scholars Central

Conference abstractPublished 11 Aug 2016

Inflammatory Bowel Disease: Therapy

Authors: Ubaldo Arturo Pimentel Aguilar

Benemerita Universidad De Puebla, Mexico

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Many therapies are avaible for patients with inflammatory bowel disease (IBD). Medical therapies include aminoslicylates drugs such as sulfasalazine, olsalazine, balsalazide, and various formulations of mesalamine; antibiotics; corticosteroids; immunosuppresive medications as azathiprine, 6-mercaptopurine (6-MP), methotrexate, and cyclosporine; and biotechnology medications such as anti-tumor necrosis factor (TNF) agents and newer agents with different mechanisms of action. Many surgical therapies also are used in patients with IBD. Some of the treatments are designed to deliver medication to specific areas of the bowel, while others act systemically. A thorough understanding of the anatomical distribution og inflammation is required in order to choose the optimal drug for a given patient. Ulcerative colitis can be divided into ulcerative proctitis, ulcerative proctosigmoiditis, left- sided ulcerative colitis, and extensive colitis or pancolitis. Crohn disease can be divided into ileitis, colitis, and ileocolitis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Ubaldo Arturo Pimentel Aguilar”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels